Inventor · disambiguated record
Margaret Anne Brimble
Also filed as: BRIMBLE MARGARET · BRIMBLE MARGARET A · BRIMBLE MARGARET ANNE
22 granted patents·13 pending applications·121 citations·filing 2002–2024
94Inventor score
Files withAUCKLAND UNISERVICES LTD7NEUREN PHARMACEUTICALS LTD7LINCOLN UNIV3OTAGO INNOVATION LTD3BRIMBLE MARGARET ANNE2
Top patents by PatentIndex Score
35 records- 0190US7714020B2Treatment of non-convulsive seizures in brain injury using G-2-methyl-prolyl glutamateNEUREN PHARMACEUTICALS LTD·Filed 2006·Granted May 11, 2010·18 cites·19 claims
- 0289US7605177B2Effects of glycyl-2 methyl prolyl glutamate on neurodegenerationNEUREN PHARMACEUTICALS LTD·Filed 2005·Granted Oct 20, 2009·14 cites·13 claims
- 0386US8067425B2Neuroprotective bicyclic compounds and methods for their useBRIMBLE MARGARET ANNE·Filed 2004·Granted Nov 29, 2011·31 cites·3 claims
- 0484US7863304B2Analogs of glycyl-prolyl-glutamateNEUREN PHARMACEUTICALS LTD·Filed 2007·Granted Jan 4, 2011·8 cites·14 claims
- 0584US7776876B2Cyclic G-2Allylproline in treatment of Parkinson's diseaseNEUREN PHARMACEUTICALS LTD·Filed 2006·Granted Aug 17, 2010·6 cites·13 claims
- 0682US8637567B2Cognitive enhancement and cognitive therapy using glycyl-L-2-methylprolyl-L-glutamic acidGLUCKMAN PETER DAVID·Filed 2010·Granted Jan 28, 2014·8 cites·16 claims
- 0781US9198420B2Rodenticidal norbormide analoguesLANDCARE RES NEW ZEALAND LTD·Filed 2013·Granted Dec 1, 2015·9 cites·20 claims
- 0880US7041314B2GPE analogs and peptidomineticsNEUREN PHARMACEUTICALS LTD·Filed 2002·Granted May 9, 2006·13 cites·16 claims
- 0976US8309684B2Synthetic analogues of neural regeneration peptidesHARRIS PAUL WILLIAM RICHARD·Filed 2010·Granted Nov 13, 2012·3 cites·3 claims
- 1074US8519127B2Cyclic glycyl-2-allyl proline and its use in treatment of peripheral neuropathyBICKERDIKE MIKE JOHN·Filed 2010·Granted Aug 27, 2013·4 cites·9 claims
- 1172US2025122132A1Nitrification inhibitorsLINCOLN UNIV·Filed 2024·Application pending·0 cites
- 1270US8138304B2Neural regeneration peptides and formulations thereofSIEG FRANK·Filed 2006·Granted Mar 20, 2012·4 cites·6 claims
- 1369US10576144B2Amino acid and peptide conjugates and conjugation processAUCKLAND UNISERVICES LTD·Filed 2014·Granted Mar 3, 2020·2 cites·18 claims
- 1466US11578013B2Nitrification inhibitorsLINCOLN UNIV·Filed 2022·Granted Feb 14, 2023·0 cites·13 claims
- 1565US2023202941A1Nitrification inhibitorsLINCOLN UNIV·Filed 2023·Application pending·0 cites
- 1663US10494344B2Carbon monoxide releasing norbornenone compoundsOTAGO INNOVATION LTD·Filed 2016·Granted Dec 3, 2019·1 cites·16 claims
- 1760US11014960B2Amino acid and peptide conjugates and uses thereofAUCKLAND UNISERVICES LTD·Filed 2019·Granted May 25, 2021·0 cites·18 claims
- 1859US2025282827A1Lipidated polymyxin analoguesAUCKLAND UNISERVICES LTD·Filed 2022·Application pending·0 cites
- 1958US8013170B2Substituted pyrrolo[1,2-d][1,4]-diazonines and treatment of brain damageHARRIS PAUL WILLIAM RICHARD·Filed 2007·Granted Sep 6, 2011·0 cites·2 claims
- 2055US11072584B2Carbon monoxide releasing norbornenone compoundsOTAGO INNOVATION LTD·Filed 2019·Granted Jul 27, 2021·0 cites·18 claims
- 2155US7485630B2Neuroprotective macrocyclic compounds and methods for their useNEUREN PHARMACEUTICALS LTD·Filed 2004·Granted Feb 3, 2009·0 cites·15 claims
- 2253US2017218023A1Synthetic analogues of neural regeneration peptidesCURONZ HOLDINGS COMPANY LTD·Filed 2017·Application pending·0 cites
- 2352US2020306370A1Amino acid and peptide conjugates and conjugation processAUCKLAND UNISERVICES LTD·Filed 2020·Application pending·0 cites
- 2451US2020347108A1Peptide Conjugates Incorporating Urea Elements and Their Use as VaccinesSAPVAX LLC·Filed 2020·Application pending·0 cites
- 2550US9650418B2Synthetic analogues of neural regeneration peptidesCURONZ HOLDINGS COMPANY LTD·Filed 2015·Granted May 16, 2017·0 cites·7 claims
- 2649US2023226065A1Anti-inflammatory compositions, methods and uses thereofEVANS JACQUELINE CAROL·Filed 2021·Application pending·0 cites
- 2749US2007004641A1Cognitive enhancement and cognitive therapy using glycyl-L-2-methylprolyl-L-glutamateNEUREN PHARMACEUTICALS LTD·Filed 2005·Application pending·0 cites
- 2849US2020353088A1Peptide conjugate cgrp receptor antagonists and methods of preparation and uses thereofAUCKLAND UNISERVICES LTD·Filed 2018·Application pending·0 cites
- 2945US2020283532A1Tumour-targeting peptide variantsCANCER RESEARCH TECH LTD·Filed 2018·Application pending·0 cites
- 3043US2022296600A1Use of a composition comprising 3,6,7-trimethyllumazine for preventing, ameliorating or treating mmp-9 associated conditions and inflammationCOMVITA LTD·Filed 2020·Application pending·0 cites
- 3141US11691949B2Quinoline sulfonamide compounds and their use as antibacterial agentsOTAGO INNOVATION LTD·Filed 2018·Granted Jul 4, 2023·0 cites·15 claims
- 3241US2020361864A1Peptide Conjugates, Conjugation Process, and Uses ThereofAUCKLAND UNISERVICES LTD·Filed 2018·Application pending·0 cites
- 3340US11464853B2Amino acid and peptide conjugates and conjugation processAUCKLAND UNISERVICES LTD·Filed 2017·Granted Oct 11, 2022·0 cites·18 claims
- 3439US10253062B2Amino acid and peptide conjugates and uses thereofBRIMBLE MARGARET ANNE·Filed 2015·Granted Apr 9, 2019·0 cites·20 claims
- 3535US2013029920A1Metal NanoparticlesBRIMBLE MARGARET A·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →